TRML logo

Tourmaline Bio (TRML) Company Overview

Profile

Full Name:

Tourmaline Bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 7, 2021

Indexes:

Not included

Description:

Tourmaline Bio is a biotechnology company focused on developing innovative therapies for cancer treatment. They use advanced technology to create personalized medicines that target specific cancer cells, aiming to improve patient outcomes and reduce side effects. Their mission is to transform cancer care through cutting-edge research and development.

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 20, 2023

Analyst ratings

Recent major analysts updates

Feb 24, 25 LifeSci Capital
Outperform
Dec 11, 24 HC Wainwright & Co.
Buy
Dec 11, 24 Guggenheim
Buy
Dec 11, 24 Cantor Fitzgerald
Overweight
Dec 6, 24 BMO Capital
Outperform
Nov 11, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
Mar 25, 24 Truist Securities
Buy
Mar 20, 24 Jefferies
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Tourmaline Bio?
  • Does Tourmaline Bio pay dividends?
  • What sector is Tourmaline Bio in?
  • What industry is Tourmaline Bio in?
  • What country is Tourmaline Bio based in?
  • When did Tourmaline Bio go public?
  • Is Tourmaline Bio in the S&P 500?
  • Is Tourmaline Bio in the NASDAQ 100?
  • Is Tourmaline Bio in the Dow Jones?
  • When was Tourmaline Bio's last earnings report?
  • When does Tourmaline Bio report earnings?
  • Should I buy Tourmaline Bio stock now?

What is the ticker symbol for Tourmaline Bio?

The ticker symbol for Tourmaline Bio is NASDAQ:TRML

Does Tourmaline Bio pay dividends?

No, Tourmaline Bio does not pay dividends

What sector is Tourmaline Bio in?

Tourmaline Bio is in the Healthcare sector

What industry is Tourmaline Bio in?

Tourmaline Bio is in the Biotechnology industry

What country is Tourmaline Bio based in?

Tourmaline Bio is headquartered in United States

When did Tourmaline Bio go public?

Tourmaline Bio's initial public offering (IPO) was on May 7, 2021

Is Tourmaline Bio in the S&P 500?

No, Tourmaline Bio is not included in the S&P 500 index

Is Tourmaline Bio in the NASDAQ 100?

No, Tourmaline Bio is not included in the NASDAQ 100 index

Is Tourmaline Bio in the Dow Jones?

No, Tourmaline Bio is not included in the Dow Jones index

When was Tourmaline Bio's last earnings report?

Tourmaline Bio's most recent earnings report was on Nov 7, 2024

When does Tourmaline Bio report earnings?

The next expected earnings date for Tourmaline Bio is Mar 19, 2025

Should I buy Tourmaline Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions